Cargando…
Potential of oncolytic viruses in the treatment of multiple myeloma
Multiple myeloma (MM) is a clonal malignancy of plasma cells that is newly diagnosed in ~30,000 patients in the US each year. While recently developed therapies have improved the prognosis for MM patients, relapse rates remain unacceptably high. To overcome this challenge, researchers have begun to...
Autor principal: | Bartee, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826297/ https://www.ncbi.nlm.nih.gov/pubmed/29503813 http://dx.doi.org/10.2147/OV.S136644 |
Ejemplares similares
-
Systemic therapy with oncolytic myxoma virus cures established residual multiple myeloma in mice
por: Bartee, Eric, et al.
Publicado: (2016) -
The Use of Oncolytic Viruses in the Treatment of Multiple Myeloma
por: Stewart, Georgia, et al.
Publicado: (2021) -
Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma Virus
por: Burton, Chase, et al.
Publicado: (2019) -
Oncolytic Viruses for Multiple Myeloma Therapy
por: Calton, Christine M., et al.
Publicado: (2018) -
The use of oncolytic virotherapy in the neoadjuvant setting
por: Thomas, Raquela J, et al.
Publicado: (2022)